1-8 of 8
Mayumi Sugita, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy Proof of Concept for Allogeneic CD123 Targeting CAR T-Cells Against Primary Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Efficient Control of Tumor Progression in PDX Model and Potential Loss of CD123 Expression in Relapsed Disease

Tianyu Cai, PhD, Kathryn L Black, PhD, Ammar S. Naqvi, PhD, Deanne Taylor, PhD, Ming Zhao, MD, Qi Yuan, Mayumi Sugita, MD, Roman Galetto, PhD, Agnès Gouble, PhD, Julianne N. P. Smith, PhD, Antonio Cavazos, Lina Han, PhD, Qi Zhang, PhD, Vinitha Mary Kuruvilla, MSc, Helen Ma, MS, Sergej Konoplev, Guilin Tang, MD, Jun Gu, MD PhD, Xiaoping Su, PhD, Sattva S Neelapu, MD, Andrew A. Lane, MD PhD, Hagop M. Kantarjian, MD, Monica L. Guzman, PhD, Naveen Pemmaraju, MD, Andrei Thomas-Tikhonenko, PhD, Marina Y Konopleva, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2659.
https://doi.org/10.1182/blood-2019-126869
Published: 2019
Journal Articles

Targeting the Epichaperome As an Effective Precision Medicine Approach in a Novel PML-SYK Fusion Acute Myeloid Leukemia

Gail J. Roboz, MD, Mayumi Sugita, MD, Juan Miguel Mosquera, MD MSc, David C Wilkes, PhD, Sarah Nataraj, PhD, Reyna A Jimenez-Flores, PhD, Rohan Bareja, LunBiao Yan, PhD, Kenneth W Eng, Jaclyn A Croyle, Theresa Y MacDonald, Zohal Noorzad, Danielle Pancirer, Shuhua Cheng, Jenny Z Xiang, MD, Luke Olson, MD, David Rickman, PhD, Wayne Tam, MD PhD, Mark A. Rubin, MD, Himisha Beltran, MD, Andrea Sboner, PhD, Koen Van Besien, MD PhD, Bob Morgan, Duane C. Hassane, PhD, Olivier Elemento, PhD, Gabriela Chiosis, PhD, Monica L. Guzman, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1435.
https://doi.org/10.1182/blood-2018-99-118764
Published: 2018
Journal Articles

Selection and Characterization of Antibody Clones Are Critical for Accurate Flow Cytometry-Based Monitoring of CD123 in Acute Myeloid Leukemia

Nicole M. Cruz, MD, Linda Lam, Mayumi Sugita, MD, Roman Galetto, PhD, Agnès Gouble, PhD, Julianne Smith, PhD, Gail J. Roboz, Monica L. Guzman, PhD
Journal: Blood
Blood (2016) 128 (22): 1693.
https://doi.org/10.1182/blood.V128.22.1693.1693
Published: 2016
Journal Articles

Allogeneic Tcrα/β Deficient CAR T-Cells Targeting CD123 Prolong Overall Survival of AML Patient-Derived Xenografts

Monica L. Guzman, PhD, Mayumi Sugita, MD, Hongliang Zong, MD PhD, Nathan Ewing-Crystal, Vicenta Trujillo-Alonso, Nuria Mencia-Trinchant, PhD, Linda Lam, Nicole M. Cruz, MD, Roman Galetto, PhD, Agnès Gouble, PhD, Duane C Hassane, PhD, Julianne Smith, PhD, Gail J. Roboz
Journal: Blood
Blood (2016) 128 (22): 765.
https://doi.org/10.1182/blood.V128.22.765.765
Published: 2016
Journal Articles

In Vivo Response to Cytarabine Chemotherapy Uncovers the Role of the Oxidative and Energetic Metabolism in the Chemoresistance of Human Primary AML Stem Cells

Nesrine Aroua, PhD, Jean-Emmanuel Sarry, PhD, Fabienne De Toni, PhD, Robin Carson, MD BA, Francois Vergez, VD PhD, Estelle Saland, Mayumi Sugita, MD, Martin Carroll, MD, Christian Recher, MDPhD, Gwenn Danet, PhD
Journal: Blood
Blood (2015) 126 (23): 4269.
https://doi.org/10.1182/blood.V126.23.4269.4269
Published: 2015
Journal Articles

Responsiveness of FLT3-ITD+ AML to Kinase Inhibition Correlates with High Allele Ratio and Relapsed Disease but Not to Inhibition of Canonical Targets

Mayumi Sugita, MD, Grace R Jeschke, Martin P. Carroll, MD, Alexander E. Perl, MD
Journal: Blood
Blood (2014) 124 (21): 2371.
https://doi.org/10.1182/blood.V124.21.2371.2371
Published: 2014
Journal Articles

Cytosine Arabinoside Chemotherapy Does Not Enrich For Leukemic Stem Cells In Xenotransplantation Model Of Human Acute Myeloid Leukemia

Fabienne de Toni, PhD, Robin L. Perry, MD, Estelle Saland, Mayumi Sugita, MD, Marion David, PhD, François Vergez, VMD, Eric Delabesse, MD, PhD, Véronique De Mas Mansat, PharmD PhD, Cécile Demur, MD, Jason Iacovoni, PhD, Stéphane Manenti, PhD, Gwenn Danet-Desnoyers, Christian Recher, MD PhD, Martin Carroll, MD, Jean-Emmanuel Sarry, PhD
Journal: Blood
Blood (2013) 122 (21): 1651.
https://doi.org/10.1182/blood.V122.21.1651.1651
Published: 2013
Journal Articles

Crenolanib (CP-868,596) Is a Potent and Selective Type I FLT3 Inhibitor That Retains Activity Against AC220 Resistance-Causing FLT3 Kinase Domain Mutants

Catherine C Smith, MD, Elisabeth Lasater, PhD, Melissa Mccreery, BS, Kimberly Lin, BS, Whitney Stewart, BS, Lauren E Damon, Alexander E Perl, MD, Grace R Jeschke, Mayumi Sugita, MD, Martin Carroll, MD, Scott C. Kogan, MD, Neil Shah, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 141.
https://doi.org/10.1182/blood.V120.21.141.141
Published: 2012